

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.26495985 |
| 2 | response to peptidoglycan (GO:0032494) | 6.26473377 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.21247665 |
| 4 | detection of other organism (GO:0098543) | 5.65143869 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.62523181 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.62523181 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.62523181 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.62523181 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.62523181 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 5.62523181 |
| 11 | detection of bacterium (GO:0016045) | 5.27326937 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.22913353 |
| 13 | negative regulation of cell killing (GO:0031342) | 5.22913353 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.22403239 |
| 15 | cellular extravasation (GO:0045123) | 5.17507687 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 5.01282586 |
| 17 | negative regulation of interleukin-12 production (GO:0032695) | 4.66797255 |
| 18 | detection of external biotic stimulus (GO:0098581) | 4.64454025 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.61641021 |
| 20 | positive regulation of mast cell activation (GO:0033005) | 4.53453819 |
| 21 | detection of molecule of bacterial origin (GO:0032490) | 4.53228682 |
| 22 | microglial cell activation (GO:0001774) | 4.48827287 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.43184805 |
| 24 | regulation of mast cell degranulation (GO:0043304) | 4.39660826 |
| 25 | respiratory burst (GO:0045730) | 4.39455599 |
| 26 | neutrophil mediated immunity (GO:0002446) | 4.39147949 |
| 27 | regulation of gamma-delta T cell activation (GO:0046643) | 4.37162486 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 4.36134246 |
| 29 | detection of biotic stimulus (GO:0009595) | 4.28673136 |
| 30 | neutrophil activation (GO:0042119) | 4.25568706 |
| 31 | positive regulation of mast cell degranulation (GO:0043306) | 4.11132028 |
| 32 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.11132028 |
| 33 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 4.10423422 |
| 34 | macrophage activation (GO:0042116) | 4.06478100 |
| 35 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.05697006 |
| 36 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.00461948 |
| 37 | myeloid cell activation involved in immune response (GO:0002275) | 3.97902596 |
| 38 | regulation of mast cell activation (GO:0033003) | 3.97692480 |
| 39 | response to muramyl dipeptide (GO:0032495) | 3.96181935 |
| 40 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.93970330 |
| 41 | response to host immune response (GO:0052572) | 3.93200757 |
| 42 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.93200757 |
| 43 | granulocyte activation (GO:0036230) | 3.92208090 |
| 44 | regulation of leukocyte degranulation (GO:0043300) | 3.91898769 |
| 45 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.88558383 |
| 46 | leukocyte aggregation (GO:0070486) | 3.76876369 |
| 47 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.74746680 |
| 48 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.72984549 |
| 49 | myeloid leukocyte mediated immunity (GO:0002444) | 3.71696196 |
| 50 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.70160673 |
| 51 | negative regulation of T cell mediated immunity (GO:0002710) | 3.66676988 |
| 52 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.61950834 |
| 53 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.60513047 |
| 54 | response to host (GO:0075136) | 3.60513047 |
| 55 | response to host defenses (GO:0052200) | 3.60513047 |
| 56 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.57532835 |
| 57 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.57325234 |
| 58 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.55522567 |
| 59 | positive regulation of B cell differentiation (GO:0045579) | 3.48907165 |
| 60 | regulation of tolerance induction (GO:0002643) | 3.47404638 |
| 61 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.46861333 |
| 62 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.42683875 |
| 63 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.40988531 |
| 64 | regulation of regulated secretory pathway (GO:1903305) | 3.40345273 |
| 65 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.35998326 |
| 66 | B cell mediated immunity (GO:0019724) | 3.35196203 |
| 67 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.33078329 |
| 68 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.31892491 |
| 69 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.25855671 |
| 70 | positive regulation of leukocyte degranulation (GO:0043302) | 3.23357806 |
| 71 | regulation of B cell differentiation (GO:0045577) | 3.21878704 |
| 72 | leukocyte degranulation (GO:0043299) | 3.21821334 |
| 73 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.21296178 |
| 74 | B cell receptor signaling pathway (GO:0050853) | 3.18406674 |
| 75 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.12005488 |
| 76 | regulation of T cell tolerance induction (GO:0002664) | 3.11943504 |
| 77 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.09866765 |
| 78 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.07877054 |
| 79 | regulation of growth of symbiont in host (GO:0044126) | 3.07877054 |
| 80 | negative regulation of growth of symbiont in host (GO:0044130) | 3.07877054 |
| 81 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.07877054 |
| 82 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.07734408 |
| 83 | defense response to protozoan (GO:0042832) | 3.05010430 |
| 84 | positive regulation of regulated secretory pathway (GO:1903307) | 3.03428832 |
| 85 | positive thymic T cell selection (GO:0045059) | 3.02481627 |
| 86 | myeloid leukocyte activation (GO:0002274) | 2.96999430 |
| 87 | positive regulation of interferon-alpha production (GO:0032727) | 2.95510856 |
| 88 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.90631328 |
| 89 | activated T cell proliferation (GO:0050798) | 2.90494342 |
| 90 | regulation of macrophage cytokine production (GO:0010935) | 2.90306195 |
| 91 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.89161227 |
| 92 | negative regulation of interleukin-8 production (GO:0032717) | 2.87521654 |
| 93 | negative regulation of interleukin-6 production (GO:0032715) | 2.86348529 |
| 94 | regulation of antigen processing and presentation (GO:0002577) | 2.83470364 |
| 95 | positive regulation of antigen processing and presentation (GO:0002579) | 2.82958810 |
| 96 | T cell migration (GO:0072678) | 2.82042608 |
| 97 | positive regulation of tolerance induction (GO:0002645) | 2.79845696 |
| 98 | regulation of interferon-alpha production (GO:0032647) | 2.79204603 |
| 99 | neutrophil chemotaxis (GO:0030593) | 2.78689083 |
| 100 | response to fungus (GO:0009620) | 2.77659429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.72672398 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.99172214 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.47916994 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.83362504 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.71045027 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.64548378 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.36640446 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.35949234 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.22177412 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.13772074 |
| 11 | VDR_24763502_ChIP-Seq_THP-1_Human | 3.12887929 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.04553821 |
| 13 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.99205508 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.79089139 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.70081202 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.65037483 |
| 17 | SPI1_23127762_ChIP-Seq_K562_Human | 2.54236085 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.53342666 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.48449165 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.47125574 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.45462325 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.42459206 |
| 23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.42396751 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.39663410 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.33729928 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 2.29359508 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.29267010 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28973929 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.27308518 |
| 30 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.26536056 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.17131775 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 2.15290565 |
| 33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.11684139 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.93045537 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.89203547 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.88431178 |
| 37 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.84719908 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 1.84694804 |
| 39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.80497292 |
| 40 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.75723037 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.74347805 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72199381 |
| 43 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.60444167 |
| 44 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.57479890 |
| 45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.56679699 |
| 46 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.56315925 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54561819 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.52397319 |
| 49 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46708495 |
| 50 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.46618816 |
| 51 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.45438621 |
| 52 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44954757 |
| 53 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44331566 |
| 54 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.44139451 |
| 55 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.43666982 |
| 56 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42512147 |
| 57 | MAF_26560356_Chip-Seq_TH2_Human | 1.40734788 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.40326634 |
| 59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.38962519 |
| 60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38182099 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36586634 |
| 62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36569883 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36468122 |
| 64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34997115 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31557731 |
| 66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30015337 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29206688 |
| 68 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28365750 |
| 69 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.24886459 |
| 70 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20492281 |
| 71 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17444217 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17396484 |
| 73 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14070389 |
| 74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12642769 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11089197 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09876812 |
| 77 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.09578588 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07923047 |
| 79 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07501493 |
| 80 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03982488 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02734528 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02657482 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01563351 |
| 84 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99104191 |
| 85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96735838 |
| 86 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92251632 |
| 87 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91794044 |
| 88 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91667997 |
| 89 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90638627 |
| 90 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.89294288 |
| 91 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84748782 |
| 92 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83117094 |
| 93 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.83001711 |
| 94 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.81009576 |
| 95 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.80402381 |
| 96 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.80124941 |
| 97 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.78004622 |
| 98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75811314 |
| 99 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.75588049 |
| 100 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.75584265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.16942248 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.13722836 |
| 3 | MP0003436_decreased_susceptibility_to | 4.02628462 |
| 4 | MP0003303_peritoneal_inflammation | 3.56052203 |
| 5 | MP0002419_abnormal_innate_immunity | 3.34082020 |
| 6 | MP0006082_CNS_inflammation | 3.15181784 |
| 7 | MP0005025_abnormal_response_to | 2.93182691 |
| 8 | MP0009785_altered_susceptibility_to | 2.90363600 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.82273320 |
| 10 | MP0001800_abnormal_humoral_immune | 2.71974584 |
| 11 | MP0005671_abnormal_response_to | 2.69482426 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.68341839 |
| 13 | MP0000685_abnormal_immune_system | 2.66569418 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.50777276 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.48708647 |
| 16 | MP0002723_abnormal_immune_serum | 2.43302347 |
| 17 | MP0001790_abnormal_immune_system | 2.43092881 |
| 18 | MP0005387_immune_system_phenotype | 2.43092881 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.41943851 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.38753618 |
| 21 | MP0001819_abnormal_immune_cell | 2.36103542 |
| 22 | MP0003828_pulmonary_edema | 2.32260493 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.24171942 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.10966663 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.10874059 |
| 26 | MP0008260_abnormal_autophagy | 2.03985154 |
| 27 | MP0001533_abnormal_skeleton_physiology | 2.03019894 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.79344023 |
| 29 | MP0002166_altered_tumor_susceptibility | 1.76804959 |
| 30 | MP0002405_respiratory_system_inflammati | 1.76470671 |
| 31 | MP0009278_abnormal_bone_marrow | 1.74734300 |
| 32 | MP0000716_abnormal_immune_system | 1.73270294 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.70878503 |
| 34 | MP0002398_abnormal_bone_marrow | 1.69539358 |
| 35 | MP0002132_abnormal_respiratory_system | 1.68373533 |
| 36 | MP0002009_preneoplasia | 1.61211272 |
| 37 | MP0004947_skin_inflammation | 1.61135870 |
| 38 | MP0003763_abnormal_thymus_physiology | 1.59938832 |
| 39 | MP0004883_abnormal_blood_vessel | 1.58847887 |
| 40 | MP0003075_altered_response_to | 1.57838093 |
| 41 | MP0009764_decreased_sensitivity_to | 1.57153955 |
| 42 | MP0001853_heart_inflammation | 1.53632079 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.53038686 |
| 44 | MP0008469_abnormal_protein_level | 1.50739016 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.49285193 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.49285193 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.47861765 |
| 48 | MP0003690_abnormal_glial_cell | 1.47841389 |
| 49 | MP0002998_abnormal_bone_remodeling | 1.45532092 |
| 50 | MP0002722_abnormal_immune_system | 1.42601992 |
| 51 | MP0000858_altered_metastatic_potential | 1.42169848 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.42048417 |
| 53 | MP0002429_abnormal_blood_cell | 1.37869555 |
| 54 | MP0001851_eye_inflammation | 1.32748886 |
| 55 | MP0003866_abnormal_defecation | 1.31808442 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.30736886 |
| 57 | MP0000569_abnormal_digit_pigmentation | 1.28605092 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.26560289 |
| 59 | MP0000604_amyloidosis | 1.25327191 |
| 60 | MP0005164_abnormal_response_to | 1.25102901 |
| 61 | MP0005166_decreased_susceptibility_to | 1.24884229 |
| 62 | MP0003806_abnormal_nucleotide_metabolis | 1.23808865 |
| 63 | MP0002396_abnormal_hematopoietic_system | 1.22682745 |
| 64 | MP0005310_abnormal_salivary_gland | 1.16673118 |
| 65 | MP0002006_tumorigenesis | 1.13028786 |
| 66 | MP0005451_abnormal_body_composition | 1.12790586 |
| 67 | MP0000703_abnormal_thymus_morphology | 1.08738803 |
| 68 | MP0000343_altered_response_to | 1.04440274 |
| 69 | MP0008004_abnormal_stomach_pH | 1.00155953 |
| 70 | MP0000015_abnormal_ear_pigmentation | 0.99748649 |
| 71 | MP0003448_altered_tumor_morphology | 0.95696836 |
| 72 | MP0009763_increased_sensitivity_to | 0.91324484 |
| 73 | MP0004381_abnormal_hair_follicle | 0.90515219 |
| 74 | MP0009840_abnormal_foam_cell | 0.82845170 |
| 75 | MP0005390_skeleton_phenotype | 0.80239461 |
| 76 | MP0001663_abnormal_digestive_system | 0.79271083 |
| 77 | MP0005075_abnormal_melanosome_morpholog | 0.78933458 |
| 78 | MP0004510_myositis | 0.78885484 |
| 79 | MP0004808_abnormal_hematopoietic_stem | 0.77385251 |
| 80 | MP0005360_urolithiasis | 0.77221112 |
| 81 | MP0005076_abnormal_cell_differentiation | 0.73129084 |
| 82 | MP0001986_abnormal_taste_sensitivity | 0.72865130 |
| 83 | MP0002277_abnormal_respiratory_mucosa | 0.72364507 |
| 84 | MP0000249_abnormal_blood_vessel | 0.71433713 |
| 85 | MP0003795_abnormal_bone_structure | 0.70845201 |
| 86 | MP0005174_abnormal_tail_pigmentation | 0.62930750 |
| 87 | MP0002933_joint_inflammation | 0.62221699 |
| 88 | MP0003329_amyloid_beta_deposits | 0.61173369 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.60961320 |
| 90 | MP0005319_abnormal_enzyme/_coenzyme | 0.59464650 |
| 91 | MP0005388_respiratory_system_phenotype | 0.57124337 |
| 92 | MP0002133_abnormal_respiratory_system | 0.57124337 |
| 93 | MP0000920_abnormal_myelination | 0.57049070 |
| 94 | MP0001873_stomach_inflammation | 0.56846683 |
| 95 | MP0003091_abnormal_cell_migration | 0.54831459 |
| 96 | MP0006054_spinal_hemorrhage | 0.54113480 |
| 97 | MP0000490_abnormal_crypts_of | 0.53344356 |
| 98 | MP0000609_abnormal_liver_physiology | 0.52332244 |
| 99 | MP0005376_homeostasis/metabolism_phenot | 0.52237477 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.50316518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 6.46727610 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.41528255 |
| 3 | Recurrent abscess formation (HP:0002722) | 6.28671612 |
| 4 | Abnormality of macrophages (HP:0004311) | 5.85421165 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.36447458 |
| 6 | Myositis (HP:0100614) | 5.32637090 |
| 7 | Orchitis (HP:0100796) | 4.79267929 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.73734666 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 4.71501206 |
| 10 | Optic neuritis (HP:0100653) | 4.71501206 |
| 11 | Stomatitis (HP:0010280) | 4.43996383 |
| 12 | Recurrent skin infections (HP:0001581) | 4.32278855 |
| 13 | Obstructive lung disease (HP:0006536) | 4.27615201 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 4.27615201 |
| 15 | Recurrent fungal infections (HP:0002841) | 4.16493740 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 4.08039452 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 3.90070997 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.85634813 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.85634813 |
| 20 | Meningitis (HP:0001287) | 3.74506685 |
| 21 | Abnormality of glycolipid metabolism (HP:0010969) | 3.67218930 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.67218930 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.67218930 |
| 24 | Gingivitis (HP:0000230) | 3.54255107 |
| 25 | Increased cerebral lipofuscin (HP:0011813) | 3.44601367 |
| 26 | Keratoconjunctivitis sicca (HP:0001097) | 3.44390262 |
| 27 | Urticaria (HP:0001025) | 3.40293761 |
| 28 | Hemoptysis (HP:0002105) | 3.31927096 |
| 29 | Vasculitis (HP:0002633) | 3.30245202 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.25148013 |
| 31 | Pulmonary infiltrates (HP:0002113) | 3.23319799 |
| 32 | Keratoconjunctivitis (HP:0001096) | 3.22427546 |
| 33 | Encephalitis (HP:0002383) | 3.15874950 |
| 34 | Chest pain (HP:0100749) | 3.14407192 |
| 35 | * Amyloidosis (HP:0011034) | 3.04913155 |
| 36 | Prolonged bleeding time (HP:0003010) | 3.00539616 |
| 37 | Gingival bleeding (HP:0000225) | 2.99885221 |
| 38 | Recurrent viral infections (HP:0004429) | 2.97864376 |
| 39 | Spontaneous hematomas (HP:0007420) | 2.96531948 |
| 40 | Arterial thrombosis (HP:0004420) | 2.95077977 |
| 41 | Episodic fever (HP:0001954) | 2.86542121 |
| 42 | Leukocytosis (HP:0001974) | 2.81852293 |
| 43 | Epistaxis (HP:0000421) | 2.81133635 |
| 44 | Dysostosis multiplex (HP:0000943) | 2.80753131 |
| 45 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.74212991 |
| 46 | Cellulitis (HP:0100658) | 2.74100609 |
| 47 | Pulmonary embolism (HP:0002204) | 2.70989117 |
| 48 | Increased IgE level (HP:0003212) | 2.68855043 |
| 49 | Vacuolated lymphocytes (HP:0001922) | 2.62667485 |
| 50 | Thrombocytosis (HP:0001894) | 2.61488739 |
| 51 | T lymphocytopenia (HP:0005403) | 2.56945795 |
| 52 | Loss of speech (HP:0002371) | 2.52833949 |
| 53 | Gangrene (HP:0100758) | 2.52424018 |
| 54 | Abnormality of T cell number (HP:0011839) | 2.46728241 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.44997140 |
| 56 | Increased serum ferritin (HP:0003281) | 2.44870129 |
| 57 | Petechiae (HP:0000967) | 2.43407176 |
| 58 | Anorexia (HP:0002039) | 2.43272225 |
| 59 | Purpura (HP:0000979) | 2.43083833 |
| 60 | Peritonitis (HP:0002586) | 2.43029572 |
| 61 | Osteomyelitis (HP:0002754) | 2.41070424 |
| 62 | Pustule (HP:0200039) | 2.41056754 |
| 63 | Abnormality of the pleura (HP:0002103) | 2.40137189 |
| 64 | Granulocytopenia (HP:0001913) | 2.35949821 |
| 65 | Inflammation of the large intestine (HP:0002037) | 2.35867510 |
| 66 | Glomerulopathy (HP:0100820) | 2.30304261 |
| 67 | Gastrointestinal inflammation (HP:0004386) | 2.24939318 |
| 68 | Abnormality of T cells (HP:0002843) | 2.22847921 |
| 69 | Hepatosplenomegaly (HP:0001433) | 2.20212717 |
| 70 | Amaurosis fugax (HP:0100576) | 2.19921360 |
| 71 | Vertigo (HP:0002321) | 2.19329109 |
| 72 | Autoimmune thrombocytopenia (HP:0001973) | 2.18865591 |
| 73 | Polyneuropathy (HP:0001271) | 2.16041824 |
| 74 | Myocardial infarction (HP:0001658) | 2.14448375 |
| 75 | Abnormality of iron homeostasis (HP:0011031) | 2.13172196 |
| 76 | Disinhibition (HP:0000734) | 2.12502262 |
| 77 | Colitis (HP:0002583) | 2.11336611 |
| 78 | Cheilitis (HP:0100825) | 2.10650872 |
| 79 | Panhypogammaglobulinemia (HP:0003139) | 2.10307450 |
| 80 | Fatigue (HP:0012378) | 2.09485230 |
| 81 | Thrombophlebitis (HP:0004418) | 2.09292193 |
| 82 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.06066441 |
| 83 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.06066441 |
| 84 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.06066441 |
| 85 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.01744789 |
| 86 | Mucopolysacchariduria (HP:0008155) | 2.01744789 |
| 87 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.01621266 |
| 88 | Skin ulcer (HP:0200042) | 2.01534759 |
| 89 | Abnormality of the peritoneum (HP:0002585) | 1.99776279 |
| 90 | Sepsis (HP:0100806) | 1.98501227 |
| 91 | Abnormality of T cell physiology (HP:0011840) | 1.97831989 |
| 92 | Abnormality of the prostate (HP:0008775) | 1.97059139 |
| 93 | Abnormality of the endocardium (HP:0004306) | 1.96168298 |
| 94 | Hypergammaglobulinemia (HP:0010702) | 1.95600718 |
| 95 | Malnutrition (HP:0004395) | 1.95067199 |
| 96 | Periodontitis (HP:0000704) | 1.92706284 |
| 97 | Increased IgM level (HP:0003496) | 1.91190195 |
| 98 | Hypochromic anemia (HP:0001931) | 1.89421823 |
| 99 | Eosinophilia (HP:0001880) | 1.86523961 |
| 100 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84798817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.30916505 |
| 2 | BLK | 3.64980684 |
| 3 | TYK2 | 3.18431113 |
| 4 | MAP2K3 | 3.10916332 |
| 5 | FES | 3.06308580 |
| 6 | MAP4K1 | 2.82179356 |
| 7 | CSK | 2.67980123 |
| 8 | PRPF4B | 2.64485942 |
| 9 | IRAK4 | 2.46570934 |
| 10 | ZAP70 | 2.29955581 |
| 11 | MAP3K14 | 2.20676690 |
| 12 | GRK6 | 2.05627357 |
| 13 | FGR | 1.99389259 |
| 14 | ERN1 | 1.96588094 |
| 15 | SYK | 1.95064821 |
| 16 | BTK | 1.94193781 |
| 17 | CSF1R | 1.76952099 |
| 18 | BMPR2 | 1.74974652 |
| 19 | MAP3K13 | 1.73898636 |
| 20 | MAP3K3 | 1.72173576 |
| 21 | JAK3 | 1.70875128 |
| 22 | TNK2 | 1.66976085 |
| 23 | TEC | 1.60867989 |
| 24 | HCK | 1.60787279 |
| 25 | KIT | 1.59405696 |
| 26 | LYN | 1.50860486 |
| 27 | TBK1 | 1.49361578 |
| 28 | TXK | 1.47496493 |
| 29 | IKBKE | 1.41105618 |
| 30 | JAK2 | 1.38676256 |
| 31 | JAK1 | 1.36151229 |
| 32 | ITK | 1.31763617 |
| 33 | TAOK3 | 1.30446704 |
| 34 | CDK19 | 1.29511778 |
| 35 | MAP3K1 | 1.25891475 |
| 36 | TAOK1 | 1.24909834 |
| 37 | LCK | 1.17130091 |
| 38 | YES1 | 1.14925456 |
| 39 | MATK | 1.13375487 |
| 40 | MAP3K11 | 1.05649434 |
| 41 | PIK3CG | 1.04523183 |
| 42 | MAP3K6 | 1.03884547 |
| 43 | IKBKB | 1.03671476 |
| 44 | PDK1 | 1.02963058 |
| 45 | KSR2 | 0.99166949 |
| 46 | IRAK2 | 0.97849001 |
| 47 | PDPK1 | 0.96520983 |
| 48 | EPHB1 | 0.95193568 |
| 49 | TGFBR2 | 0.94500462 |
| 50 | MARK3 | 0.92026087 |
| 51 | IRAK1 | 0.86444526 |
| 52 | STK10 | 0.86176406 |
| 53 | SIK3 | 0.84161354 |
| 54 | MAPK12 | 0.83564537 |
| 55 | MAPK7 | 0.82550518 |
| 56 | GRK7 | 0.82239761 |
| 57 | MOS | 0.78208555 |
| 58 | MAP3K2 | 0.77501543 |
| 59 | MARK2 | 0.73076625 |
| 60 | TAOK2 | 0.68699011 |
| 61 | FGFR3 | 0.68069058 |
| 62 | TRIB3 | 0.66023473 |
| 63 | LRRK2 | 0.64434661 |
| 64 | CDK6 | 0.64256089 |
| 65 | FYN | 0.63484241 |
| 66 | IRAK3 | 0.58962048 |
| 67 | RPS6KC1 | 0.56092785 |
| 68 | RPS6KL1 | 0.56092785 |
| 69 | PTK6 | 0.54980653 |
| 70 | MAP3K7 | 0.53537056 |
| 71 | MAP3K5 | 0.53107945 |
| 72 | TRPM7 | 0.52545336 |
| 73 | TESK2 | 0.51301650 |
| 74 | MAP2K4 | 0.50128277 |
| 75 | SGK3 | 0.48112254 |
| 76 | PRKCQ | 0.47875813 |
| 77 | RPS6KA6 | 0.46308187 |
| 78 | CAMKK2 | 0.45672347 |
| 79 | CDC42BPA | 0.43494816 |
| 80 | ABL1 | 0.40961369 |
| 81 | MAP2K6 | 0.39889884 |
| 82 | STK11 | 0.39146595 |
| 83 | HIPK2 | 0.39140682 |
| 84 | MAP2K2 | 0.38461100 |
| 85 | PIM1 | 0.37902436 |
| 86 | DYRK1B | 0.37724484 |
| 87 | RET | 0.37080878 |
| 88 | PTK2B | 0.36867601 |
| 89 | MAPKAPK2 | 0.35445623 |
| 90 | RPS6KA4 | 0.34528817 |
| 91 | RAF1 | 0.34030474 |
| 92 | ARAF | 0.33077929 |
| 93 | PRKD2 | 0.31587964 |
| 94 | TTN | 0.30527421 |
| 95 | SIK2 | 0.30162955 |
| 96 | FGFR4 | 0.30068316 |
| 97 | PRKCD | 0.29488079 |
| 98 | DAPK2 | 0.28903427 |
| 99 | RPS6KA2 | 0.28097198 |
| 100 | SGK2 | 0.26981717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.38013902 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.31138204 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.92992902 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.60860648 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.57632692 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.57392725 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.57280736 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.42523639 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.40709760 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.36869254 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.05936265 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.03909730 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.03876636 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.98428832 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.97089475 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.94075203 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.88581590 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.85670090 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.82032612 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.79574876 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.73376248 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.68640151 |
| 23 | Phagosome_Homo sapiens_hsa04145 | 1.63251412 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.62243984 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.60448466 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.60415282 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.55583778 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.54201685 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.50485845 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.50233682 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.47808141 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.41759284 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.40966200 |
| 34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.39593283 |
| 35 | Measles_Homo sapiens_hsa05162 | 1.35576792 |
| 36 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.35549931 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.30798910 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22932407 |
| 39 | Platelet activation_Homo sapiens_hsa04611 | 1.14088920 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13644003 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.12711380 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12092590 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.10942853 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.10004371 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06767246 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.01877190 |
| 47 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.00561812 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98446169 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.94360766 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78576245 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 0.77399027 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76356516 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 0.76090776 |
| 54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75384033 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74898423 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.74334861 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73343414 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72685133 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71648501 |
| 60 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.70189880 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67650764 |
| 62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66037754 |
| 63 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65449828 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64656316 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64512745 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63939286 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63127533 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58981189 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57875526 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56392586 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56212897 |
| 72 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56067804 |
| 73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53468039 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53418668 |
| 75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50576371 |
| 76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50345676 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49664854 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.49605818 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49119870 |
| 80 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47859829 |
| 81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47628655 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46270650 |
| 83 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43113864 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40434042 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39510845 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38722221 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38553078 |
| 88 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38237068 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37430071 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.37377257 |
| 91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37325808 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36196011 |
| 93 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34307530 |
| 94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.34218300 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33227021 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32616441 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32161179 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31664569 |
| 99 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.29927717 |
| 100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.29459403 |

